Skip to main content
MyCapitol LogoMyCapitol

HR 6977 · 118th Congress

Independent Drug Value Assessment Act of 2024

This bill creates a new system where the federal government will hire independent organizations to evaluate whether newly approved drugs are actually worth their price tags. Right now, pharmaceutical companies essentially set their own prices with little government oversight of whether those prices match the actual…

Sponsor
Nadler, Jerrold (D-NY)
Introduced
2024-01-11
Policy area
Health
Latest action
Referred to the Subcommittee on Health.

Digging through Congress... 🔍